{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:57:35Z","timestamp":1783133855585,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013865","name":"Charit\u00e9 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health at Charit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejca.2025.115280","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:06:27Z","timestamp":1738843587000},"page":"115280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-7038","authenticated-orcid":false,"given":"Stanislav","family":"Rosnev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Peuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Piwonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Ihlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Leyvraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00f6bs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"de Bucourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-1958","authenticated-orcid":false,"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Ochsenreither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Rittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115280_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2025.115280_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1755-3768.1982.tb08371.x","article-title":"Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952","volume":"60","author":"Jensen","year":"1982","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ejca.2025.115280_bib3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejca.2025.115280_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/COC.0b013e3182546a6b","article-title":"Delayed systemic recurrence of uveal melanoma","volume":"36","author":"Kolandjian","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15","volume":"119","author":"Collaborative Ocular Melanoma Study","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ejca.2025.115280_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.961517","article-title":"Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases","volume":"12","author":"Wei","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/CMR.0000000000000575","article-title":"Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis","volume":"29","author":"Rantala","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2025.115280_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115280_bib9","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMoa2304753","article-title":"Three-year overall survival with tebentafusp in metastatic uveal melanoma","volume":"389","author":"Hassel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115280_bib10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejca.2025.115280_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ophtha.2018.03.011","article-title":"The cancer genome Atlas project: an integrated molecular view of uveal melanoma","volume":"125","author":"Jager","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejca.2025.115280_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ejca.2025.115280_bib13","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115280_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2025.115280_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1167\/iovs.07-0786","article-title":"Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma","volume":"49","author":"Maat","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejca.2025.115280_bib16","first-page":"394","article-title":"Lymphocytic infiltration in choroidal melanoma and its prognostic significance","volume":"97","author":"Davidorf","year":"1977","journal-title":"Trans Ophthalmol Soc U K (1962)"},{"key":"10.1016\/j.ejca.2025.115280_bib17","first-page":"355","article-title":"Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice","volume":"20","author":"Niederkorn","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejca.2025.115280_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.preteyeres.2009.06.002","article-title":"Immune escape mechanisms of intraocular tumors","volume":"28","author":"Niederkorn","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ejca.2025.115280_bib19","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1038\/s41598-024-55675-5","article-title":"Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis","volume":"14","author":"Yamada","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2025.115280_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1200\/JCO.20.03274","article-title":"Dual immunological checkpoint blockade for uveal melanoma","volume":"39","author":"Khan","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.hpb.2019.11.002","article-title":"Systematic review of liver directed therapy for uveal melanoma hepatic metastases","volume":"22","author":"Rowcroft","year":"2020","journal-title":"HPB (Oxf)"},{"key":"10.1016\/j.ejca.2025.115280_bib22","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/s41591-022-02015-7","article-title":"Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial","volume":"28","author":"Carvajal","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2025.115280_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231160140","article-title":"Tebentafusp: a first-in-class treatment for metastatic uveal melanoma","volume":"15","author":"Howlett","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215914","article-title":"The molecular biology of peritoneal metastatic disease","volume":"15","author":"Bootsma","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejca.2025.115280_bib25","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115280_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s13193-022-01592-w","article-title":"Peritoneal metastases from extraperitoneal primary tumors: incidence, treatment, and survival from a nationwide database","volume":"14","author":"Rijken","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ejso.2018.07.049","article-title":"Peritoneal metastases from extra-abdominal cancer - a population-based study","volume":"44","author":"Flanagan","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133445","article-title":"Development of the NOGGO GIS v1 assay, a comprehensive hybrid-capture-based NGS assay for therapeutic stratification of homologous repair deficiency driven tumors and clinical validation","volume":"15","author":"Willing","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2025.115280_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.ejca.2025.115280_bib30","article-title":"Peritoneal metastases from breast cancer: a scoping review","volume":"11","author":"Beniey","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ejca.2025.115280_bib31","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3390\/curroncol30030224","article-title":"Therapeutic strategies and oncological outcome of peritoneal metastases from lung cancer: a systematic review and pooled analysis","volume":"30","author":"Siragusa","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib32","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/annonc\/mdz176","article-title":"Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study","volume":"30","author":"Khoja","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2016.06.002","article-title":"Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European Ophthalmic Oncology Group","volume":"168","author":"Kivela","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ejca.2025.115280_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.20.00550","article-title":"Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)","volume":"39","author":"Piulats","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115280_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133359","article-title":"Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis","volume":"13","author":"Koch","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2025.115280_bib36","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00262-021-03090-4","article-title":"Clinical determinants of long-term survival in metastatic uveal melanoma","volume":"71","author":"Koch","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejca.2025.115280_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.32522","article-title":"Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy","volume":"126","author":"Pires da Silva","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2025.115280_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001501","article-title":"Comprehensive analysis of cutaneous and uveal melanoma liver metastases","volume":"8","author":"Hoefsmit","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2025.115280_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13046-021-01947-1","article-title":"The immune cell landscape of metastatic uveal melanoma correlates with overall survival","volume":"40","author":"Tosi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.115280_bib40","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.11-9280","article-title":"Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma","volume":"53","author":"Bronkhorst","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejca.2025.115280_bib41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00262-017-1991-1","article-title":"Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment","volume":"66","author":"Gezgin","year":"2017","journal-title":"Cancer Immunol Immunother"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:36:42Z","timestamp":1777351002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S0959804925000619"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115280","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115280"}}